AI Breakfast: Modelling Molecules

​We're back with our latest installment of our AI Breakfast series.

​From the human microbiome to advanced materials, molecules define the frontiers of innovation in both biology and chemistry.

​This breakfast and panel discussion brings together pioneers building AI models to understand drug–microbiome interactions and to design entirely new classes of materials. Together, they’ll dive into how AI is transforming our ability to predict, design, and translate molecular insights into breakthroughs in medicine, safety, and sustainability.

​​​Joining the discussion: Jenny Yang (CEO, Stealth AI Biotech), Pierre Salvy (CTO Cambrium), Jelena Ivanovska (Chief Scientific Officer, Provolut), Matilda Glynn-Henley (Investor, Merantix Capital)

🎟️ Register here to secure a spot!